Outcome of the meeting of the Board of Directors held on August 19, 2021 Receipt of Observation Letters from BSE Limited and National Stock Exchange of India Limited in relation to the proposed Scheme of Arrangement between the Aarti Industries Limited ('AIL' / Demerged Company) and Aarti Pharmalabs Limited (Formerly Known as Aarti Organics Limited) (' APL'/ Resulting Company) and their respective Shareholders (As per BSE Announcement Dated on 10/11/2021) Certificate issued by the Merchant Banker pursuant to SEBI Circular No. CFD/DlL3/CIR/2017/21 dated March 10, 2017 as amended from time to time. (As Per BSE Announcement Dated on 01/02/2022) Intimation of order of the NCLT approving the scheme of Arrangement between Aarti Industries Limited and Aarti Pharmalabs Limited and their Shareholders. (As per BSE Announcement Dated on 23/9/2022) Record date for the purpose of Scheme of Demerger is Thursday, October 20, 2022. (As Per BSE Announcement Dated on 26.09.2022) Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (for Demerger) as approved by the Hon'ble National Company Law Tribunal, Ahmedabad Bench, Aarti Industries Ltd has fixed Record Date for the purpose of determining the entitlement of its shareholders to Equity shares of Aarti Pharmalabs Ltd, as per details given below: COMPANY NAME CODE Aarti Industries Ltd (524208) RECORD DATE 20.10.2022 PURPOSE As per the Scheme of Arrangement sanctioned by the Hon'ble National Company Law Tribunal, Ahmedabad Bench, between, Aarti Industries Ltd (Demerged Company) and Aarti Pharmalabs Ltd (Resulting Company) and their Respective Shareholders and Creditors: - Upon the coming into effect of the Scheme and in consideration of the transfer of the Pharma Division of Aarti Industries Ltd into Aarti Pharmalabs Ltd; Aarti Pharmalabs Ltd shall issue and allot Equity Shares to the shareholders of Aarti Industries Ltd in the following proportion: '1 Fully Paid Up Equity Share of Rs. 5/- each of Aarti Pharmalabs Ltd shall be issued and alloted For every 4 Fully Paid Up Equity Shares of Rs.5/- each held in Aarti Industries Ltd' EX-ENTITLEMENT FROM DATE & SETT. NO. 19/10/2022 DR-139/2022-2023 Note: (1) Pursuant to SEBI Circular No. CIR/MRD/DP/01/2012 dated January 20, 2012; the aforesaid scrip shall be a part of Call Auction in Pre-open Session on 19th September, 2022. (2) Subject to compliance with requisite formalities, the shares of Resulting company No. 1 i.e. Aarti Pharmalabs Ltd will be listed on BSE Limited. (As Per BSE Notice Dated on 14.10.2022) Cost of acquisition of shares of Aarti Industries Limited and Aarti Pharmalabs Limited as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961 (As Per BSE Announcement Dated on 31.10.2022)